Ann Dermatol.  2016 Apr;28(2):271-272. 10.5021/ad.2016.28.2.271.

A Case of Cyclosporine-Induced Sebaceous Hyperplasia in a Renal Transplant Patient Successfully Treated with Isotretinoin

• Jung HY
• Kim M
• Cho BK
• Park HJ

• KMID: 2171397
• DOI: http://doi.org/10.5021/ad.2016.28.2.271

Abstract

No abstract available.

MeSH Terms

Humans
Hyperplasia*
Isotretinoin*
Isotretinoin

Figure

• 

  Fig. 1 (A) Prominent multiple hyperplastic sebaceous glands seen as skin-colored papules (arrows) scattered on the right side of the face after treatment of cyclosporine for 11 years and tacrolimus for 4 years. (B) Sebaceous hyperplasia almost completely cleared after 2 months of oral isotretinoin.

Reference

1. Perrett CM, McGregor J, Barlow RJ, Karran P, Proby C, Harwood CA. Topical photodynamic therapy with methyl aminolevulinate to treat sebaceous hyperplasia in an organ transplant recipient. Arch Dermatol. 2006; 142:781–782.

2. McDonald SK, Goh MS, Chong AH. Successful treatment of cyclosporine-induced sebaceous hyperplasia with oral isotretinoin in two renal transplant recipients. Australas J Dermatol. 2011; 52:227–230.

3. Burton CS, Sawchuk WS. Premature sebaceous gland hyperplasia: successful treatment with isotretinoin. J Am Acad Dermatol. 1985; 12:182–184.

4. Lugo-Janer G, Sánchez JL, Santiago-Delpin E. Prevalence and clinical spectrum of skin diseases in kidney transplant recipients. J Am Acad Dermatol. 1991; 24:410–414.

5. Taylor AE, Shuster S. Skin cancer after renal transplantation: the causal role of azathioprine. Acta Derm Venereol. 1992; 72:115–119.